17 results
424B4
EVAX
Evaxion Biotech A/S
5 Nov 21
Prospectus supplement with pricing info
4:47pm
the standards for approval.
Accelerated Approval Pathway and Regenerative Medicine Advanced Therapy Designation
The FDA may grant accelerated approval … by the FDA.
Accelerated approval pathways are available for regenerative medicine therapies that meet certain conditions. Regenerative medicine therapies
F-1/A
EVAX
Evaxion Biotech A/S
3 Nov 21
Registration statement (foreign) (amended)
7:50am
process, but do not change the standards for approval.
Accelerated Approval Pathway and Regenerative Medicine Advanced Therapy Designation
The FDA may … are subject to prior review by the FDA.
Accelerated approval pathways are available for regenerative medicine therapies that meet certain conditions
F-1
k1g8dhgeuqa6466h 11p
26 Oct 21
Registration statement (foreign)
7:02am
DRS
zsdn101
25 Jun 21
Draft registration statement
12:00am
20-F
m5sitn47ilab5pg
7 Apr 21
Annual report (foreign)
4:31pm
424B4
xyejlabcfpit8
5 Feb 21
Prospectus supplement with pricing info
4:53pm
F-1/A
xu2aut91u5flam0hyywt
1 Feb 21
Registration statement (foreign) (amended)
4:56pm
F-1/A
hgbp 1csjpx3pxh1
25 Jan 21
Registration statement (foreign) (amended)
7:01am
F-1/A
zlvuo4qid13ukntofm
19 Jan 21
Registration statement (foreign) (amended)
5:05pm
F-1
7br7aibdwg4j sk
8 Jan 21
Registration statement (foreign)
4:54pm
DRS/A
076fbc3y6x5
4 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
wq3ntla61g
16 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
mt52yn bfv2fx3h8
25 Nov 20
Draft registration statement (amended)
12:00am
DRS
q6k81bfe6mzh9ewd9cq
22 Oct 20
Draft registration statement
12:00am
- Prev
- 1
- Next